Scott Lauder - Net Worth and Insider Trading
Scott Lauder Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Lauder owns 1 companies in total, including Disc Medicine Inc (IRON) .
Click here to see the complete history of Scott Lauder’s form 4 insider trades.
Insider Ownership Summary of Scott Lauder
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IRON | Disc Medicine Inc | 2021-02-05 | Chief Technology Officer |
Scott Lauder Trading Performance
Scott Lauder Ownership Network
Ownership Network List of Scott Lauder
Ownership Network Relation of Scott Lauder
Scott Lauder Owned Company Details
What does Disc Medicine Inc do?
Who are the key executives at Disc Medicine Inc?
Scott Lauder is the Chief Technology Officer of Disc Medicine Inc. Other key executives at Disc Medicine Inc include Chief Medical Officer William Jacob Savage , director & 10 percent owner Orbimed Advisors Llc , and director & 10 percent owner Mona Ashiya .
Disc Medicine Inc (IRON) Insider Trades Summary
Over the past 18 months, Scott Lauder made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 48,126 shares made by William Richard White , a net sale of 75,429 shares made by Kevin Bitterman , and a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. .
In summary, during the past 3 months, insiders sold 12,495 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 12,495 shares. During the past 18 months, 3,914,721 shares of Disc Medicine Inc (IRON) were sold and 388,891 shares were bought by its insiders, resulting in a net sale of 3,525,830 shares.
Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Disc Medicine Inc Insider Transactions
Scott Lauder Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Lauder. You might contact Scott Lauder via mailing address: C/o Gemini Therapeutics, Inc., One Kendall Square, Building 300, Cambridge Ma 02139.